Community Outreach

Co-Founder of Diversity Alliance for Science in 2008

In response to a drive drug development pipeline, Diversity Alliance for Science (DA4S) was born. DA4S believes that diversity fuels scientific innovation. Its primary mission is to identify and develop diverse suppliers in the clinical and scientific industry.

DA4S is a 501©3, non-profit organization that aims to foster relationships between diverse businesses (minority, women, disabled, small disadvantaged, HUBZone, woman-owned, small, veteran, service disabled veteran, and lesbian/gay/bisexual/transgender) and government agencies, pharmaceutical firms, bio tech companies and academic medical centers. Their goal to collaborate on best practices to foster inclusion of diverse businesses in clinical trials, scientific research and development that result in medicines and therapeutics that fight diseases.

Podcast by GSK, A10, and Diversity Alliance for Science

It supports owned diverse businesses in the following and/or related areas;

  • Clinical research
  • Clinical trials
  • Analytical services
  • Drug Packaging
  • Printing/labeling
  • Bar code
  • Biotechnology support services
  • Virology services
  • Drug analysis or assay
  • Central laboratories
  • Clinical data management
  • Stability testing
  • Animal Studies
  • Biomarkers analysis
  • Chemical synthesis
  • Biology services
  • Pharmacokinetic services
  • DNA/RNA extraction
  • IRBs( Independent Review Boards)
  • Medicinal chemistry
  • Patient recruitment
  • Drug discovery and related services

DA4S has an annual conference held in May, and assembles a select number of high-level life science executives, representing Fortune 500 healthcare organizations and some of the best diverse suppliers in the world. This intimate forum has proven beneficial in forging more one-on-one networking opportunities, resulting in identifying diverse suppliers qualified to bid and win projects; procurement representatives being able to integrate niche new suppliers within their supply chain; and industry knowledge exchange.


Board of Directors

Genentech

Tom Thattacherry
President

CQ Fluency

Elisabete Miranda
Vice President

EMD

Christine Sproule
Treasurer

Pfizer

Karima Wilkins-Smartt
Secretary

GlaxoSmithKline

Sylvester Wilkins
Board Member

Henry Schein

Susan T. Vassallo
Board Member

Novartis

Sheri Shafir
Board Member – Conference Tri-Chair

Sanofi

Kathleen Castore
Board Member – Conference Tri-Chair

A10 Clinical Solutions

Leah Brown
Founding Board Member

Johnson & Johnson

Dharmesh Dubey
Board Member

Amgen

Jinus Moghbeli
Board Member

Merck

Kamlesh V. Patel
Board Member

Bright Pharmaceutical Services

Alison Macpherson
Board Member

U.S. Department of Commerce

Ronald Uba
Board Member

Ancillare

Joanne Santomauro
Board Member

Caligor RX

Tammy Bishop
Board Member

Takeda

Joyce Eriksen Eggers
Board Member

SlateBelt Safety

Robert Williams
Board Member

Bristol Myers Squibb

Fal Vaidya
Board Member

Quality Biological, Inc.

Angela Graham
Board Member

Medisys Health Communications

Anna Walz
Board Member

The DA4S and A10 believe that DIVERSITY is the Engine to Scientific Innovation!